Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art

Chang Liu , Xiaohe Jiang , Yong Gan , Miaorong Yu
{"title":"Engineering nanoparticles to overcome the mucus barrier for drug delivery: Design, evaluation and state-of-the-art","authors":"Chang Liu ,&nbsp;Xiaohe Jiang ,&nbsp;Yong Gan ,&nbsp;Miaorong Yu","doi":"10.1016/j.medidd.2021.100110","DOIUrl":null,"url":null,"abstract":"<div><p>Mucus is a viscoelastic hydrogel that lubricates and protects mucosal tissues such as the eyes, lung, gastrointestinal tract, and vagina. Nanoparticle-based drug delivery systems (DDSs) can be easily trapped in the mucus network by steric obstruction and/or binding interactions and then are efficiently cleared away with rapid mucus turnover, thereby limiting mucosal drug delivery efficacy. Modulating the physicochemical properties of nanoparticles (NPs), including size, surface hydrophilicity and charge, shape, and rigidity, is an effective method to overcome the mucus barrier. This review first describes the protective barrier properties of mucus and how mucus affects the fate of NPs. It then reviews the techniques for evaluating particle movement in mucus, including macroscopic diffusivity and microcosmic diffusion mechanisms. The state-of-the-art strategies exploited by researchers to overcome the mucus barrier by using NPs are discussed. Finally, the dilemma and solutions of balancing both mucus penetration and cellular uptake barriers are discussed.</p></div>","PeriodicalId":33528,"journal":{"name":"Medicine in Drug Discovery","volume":"12 ","pages":"Article 100110"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590098621000312/pdfft?md5=c24609916f2f90aafb06b26c42cb7076&pid=1-s2.0-S2590098621000312-main.pdf","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine in Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590098621000312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 14

Abstract

Mucus is a viscoelastic hydrogel that lubricates and protects mucosal tissues such as the eyes, lung, gastrointestinal tract, and vagina. Nanoparticle-based drug delivery systems (DDSs) can be easily trapped in the mucus network by steric obstruction and/or binding interactions and then are efficiently cleared away with rapid mucus turnover, thereby limiting mucosal drug delivery efficacy. Modulating the physicochemical properties of nanoparticles (NPs), including size, surface hydrophilicity and charge, shape, and rigidity, is an effective method to overcome the mucus barrier. This review first describes the protective barrier properties of mucus and how mucus affects the fate of NPs. It then reviews the techniques for evaluating particle movement in mucus, including macroscopic diffusivity and microcosmic diffusion mechanisms. The state-of-the-art strategies exploited by researchers to overcome the mucus barrier by using NPs are discussed. Finally, the dilemma and solutions of balancing both mucus penetration and cellular uptake barriers are discussed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
工程纳米颗粒克服黏液屏障给药:设计、评估和最新技术
粘液是一种粘弹性水凝胶,对眼睛、肺、胃肠道和阴道等粘膜组织起到润滑和保护作用。基于纳米颗粒的药物递送系统(dds)很容易因位阻和/或结合相互作用而被困在粘液网络中,然后被快速的粘液周转有效地清除,从而限制了粘膜药物递送的效果。调节纳米颗粒(NPs)的物理化学性质,包括大小、表面亲水性和电荷、形状和硬度,是克服黏液屏障的有效方法。本文首先介绍了粘液的保护屏障特性以及粘液如何影响NPs的命运。然后回顾了评估黏液中颗粒运动的技术,包括宏观扩散率和微观扩散机制。讨论了研究人员利用NPs克服粘液屏障的最新策略。最后,讨论了平衡黏液渗透和细胞摄取屏障的困境和解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medicine in Drug Discovery
Medicine in Drug Discovery Medicine-Pharmacology (medical)
CiteScore
8.30
自引率
0.00%
发文量
30
审稿时长
21 days
期刊介绍:
期刊最新文献
Recent approaches in nanotoxicity assessment for drug delivery applications: Challenges and prospects Structural features of arrestin-mediated GPCR signaling The distribution of Hypocretin/Orexin receptor mRNA in the mouse and human brain Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials Pharmacological effects of dragon’s blood from Dranaena cochinchinensis (Lour.) S.C. Chen and its application in cardiovascular diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1